Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TVG-PRRSV vaccine
- Development stage
- Preclinical
- Lead developer
- TVG
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
01
Overview
TVG-PRRSV vaccine is a herpesvirus-based viral-vector vaccine developed by The Vaccine Group (TVG) for the prevention of Porcine Reproductive and Respiratory Syndrome (PRRS) in pigs. The vaccine utilizes a herpesvirus vector to deliver and express antigens from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). This approach is designed to induce robust protective immunity, specifically T-cell responses, which have been shown in preclinical studies to prevent lung disease associated with PRRSV infection in swine. The vaccine is currently in preclinical development.
- Other names
- Porcine Reproductive and Respiratory Syndrome vaccinePRRSV vaccine
02
Targets
PRRSV M (PRRSV membrane protein)PRRSV antigen (Porcine reproductive and respiratory syndrome virus antigen)
Beyond the preview
Go deeper on TVG-PRRSV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TVG-PRRSV vaccine.